Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice

Ketrija Touw, Saikat Chakraborty, Wenwu Zhang, Alexander Obukhov, Johnathan Tune, Susan Gunst, B. Herring

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Seventy-six percent of diabetic patients develop gastrointestinal symptoms, such as constipation. However, the direct effects of diabetes on intestinal smooth muscle are poorly described. This study aimed to identify the role played by smooth muscle in mediating diabetes-induced colonic dysmotility. To induce type 1 diabetes, mice were injected intraperitoneally with low-dose streptozotocin once a day for 5 days. Animals developed hyperglycemia (>200 mg/dl) 1 wk after the last injection and were euthanized 7-8 wk after the last treatment. Computed tomography demonstrated decreased overall gastrointestinal motility in the diabetic mice. In vitro contractility of colonic smooth muscle rings from diabetic mice was also decreased. Fura-2 ratiometric Ca 2+ imaging showed attenuated Ca 2+ increases in response to KCl stimulation that were associated with decreased light chain phosphorylation in diabetic mice. The diabetic mice also exhibited elevated basal Ca 2+ levels, increased myosin phosphatase targeting subunit 1 expression, and significant changes in expression of Ca 2+ handling proteins, as determined by quantitative RT-PCR and Western blotting. Mice that were hyperglycemic for <1 wk also showed decreased colonic contractile responses that were associated with decreased Ca 2+ increases in response to KCl stimulation, although without an elevation in basal Ca 2+ levels or a significant change in the expression of Ca 2+ signaling molecules. These data demonstrate that type 1 diabetes is associated with decreased depolarization-induced Ca 2+ influx in colonic smooth muscle that leads to attenuated myosin light chain phosphorylation and impaired colonic contractility.

Original languageEnglish
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume302
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Calcium Signaling
Smooth Muscle
Type 1 Diabetes Mellitus
Myosin-Light-Chain Phosphatase
Phosphorylation
Obese Mice
Myosin Light Chains
Gastrointestinal Motility
Fura-2
Constipation
Streptozocin
Hyperglycemia
Western Blotting
Tomography
Light
Polymerase Chain Reaction
Injections
Proteins

Keywords

  • Colon
  • Streptozotocin
  • Voltage-gated calcium channel

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology (medical)
  • Physiology
  • Hepatology

Cite this

Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice. / Touw, Ketrija; Chakraborty, Saikat; Zhang, Wenwu; Obukhov, Alexander; Tune, Johnathan; Gunst, Susan; Herring, B.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 302, No. 1, 01.2012.

Research output: Contribution to journalArticle

@article{ba893ed170f04f5092f12ee990653141,
title = "Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice",
abstract = "Seventy-six percent of diabetic patients develop gastrointestinal symptoms, such as constipation. However, the direct effects of diabetes on intestinal smooth muscle are poorly described. This study aimed to identify the role played by smooth muscle in mediating diabetes-induced colonic dysmotility. To induce type 1 diabetes, mice were injected intraperitoneally with low-dose streptozotocin once a day for 5 days. Animals developed hyperglycemia (>200 mg/dl) 1 wk after the last injection and were euthanized 7-8 wk after the last treatment. Computed tomography demonstrated decreased overall gastrointestinal motility in the diabetic mice. In vitro contractility of colonic smooth muscle rings from diabetic mice was also decreased. Fura-2 ratiometric Ca 2+ imaging showed attenuated Ca 2+ increases in response to KCl stimulation that were associated with decreased light chain phosphorylation in diabetic mice. The diabetic mice also exhibited elevated basal Ca 2+ levels, increased myosin phosphatase targeting subunit 1 expression, and significant changes in expression of Ca 2+ handling proteins, as determined by quantitative RT-PCR and Western blotting. Mice that were hyperglycemic for <1 wk also showed decreased colonic contractile responses that were associated with decreased Ca 2+ increases in response to KCl stimulation, although without an elevation in basal Ca 2+ levels or a significant change in the expression of Ca 2+ signaling molecules. These data demonstrate that type 1 diabetes is associated with decreased depolarization-induced Ca 2+ influx in colonic smooth muscle that leads to attenuated myosin light chain phosphorylation and impaired colonic contractility.",
keywords = "Colon, Streptozotocin, Voltage-gated calcium channel",
author = "Ketrija Touw and Saikat Chakraborty and Wenwu Zhang and Alexander Obukhov and Johnathan Tune and Susan Gunst and B. Herring",
year = "2012",
month = "1",
doi = "10.1152/ajpgi.00183.2011",
language = "English",
volume = "302",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice

AU - Touw, Ketrija

AU - Chakraborty, Saikat

AU - Zhang, Wenwu

AU - Obukhov, Alexander

AU - Tune, Johnathan

AU - Gunst, Susan

AU - Herring, B.

PY - 2012/1

Y1 - 2012/1

N2 - Seventy-six percent of diabetic patients develop gastrointestinal symptoms, such as constipation. However, the direct effects of diabetes on intestinal smooth muscle are poorly described. This study aimed to identify the role played by smooth muscle in mediating diabetes-induced colonic dysmotility. To induce type 1 diabetes, mice were injected intraperitoneally with low-dose streptozotocin once a day for 5 days. Animals developed hyperglycemia (>200 mg/dl) 1 wk after the last injection and were euthanized 7-8 wk after the last treatment. Computed tomography demonstrated decreased overall gastrointestinal motility in the diabetic mice. In vitro contractility of colonic smooth muscle rings from diabetic mice was also decreased. Fura-2 ratiometric Ca 2+ imaging showed attenuated Ca 2+ increases in response to KCl stimulation that were associated with decreased light chain phosphorylation in diabetic mice. The diabetic mice also exhibited elevated basal Ca 2+ levels, increased myosin phosphatase targeting subunit 1 expression, and significant changes in expression of Ca 2+ handling proteins, as determined by quantitative RT-PCR and Western blotting. Mice that were hyperglycemic for <1 wk also showed decreased colonic contractile responses that were associated with decreased Ca 2+ increases in response to KCl stimulation, although without an elevation in basal Ca 2+ levels or a significant change in the expression of Ca 2+ signaling molecules. These data demonstrate that type 1 diabetes is associated with decreased depolarization-induced Ca 2+ influx in colonic smooth muscle that leads to attenuated myosin light chain phosphorylation and impaired colonic contractility.

AB - Seventy-six percent of diabetic patients develop gastrointestinal symptoms, such as constipation. However, the direct effects of diabetes on intestinal smooth muscle are poorly described. This study aimed to identify the role played by smooth muscle in mediating diabetes-induced colonic dysmotility. To induce type 1 diabetes, mice were injected intraperitoneally with low-dose streptozotocin once a day for 5 days. Animals developed hyperglycemia (>200 mg/dl) 1 wk after the last injection and were euthanized 7-8 wk after the last treatment. Computed tomography demonstrated decreased overall gastrointestinal motility in the diabetic mice. In vitro contractility of colonic smooth muscle rings from diabetic mice was also decreased. Fura-2 ratiometric Ca 2+ imaging showed attenuated Ca 2+ increases in response to KCl stimulation that were associated with decreased light chain phosphorylation in diabetic mice. The diabetic mice also exhibited elevated basal Ca 2+ levels, increased myosin phosphatase targeting subunit 1 expression, and significant changes in expression of Ca 2+ handling proteins, as determined by quantitative RT-PCR and Western blotting. Mice that were hyperglycemic for <1 wk also showed decreased colonic contractile responses that were associated with decreased Ca 2+ increases in response to KCl stimulation, although without an elevation in basal Ca 2+ levels or a significant change in the expression of Ca 2+ signaling molecules. These data demonstrate that type 1 diabetes is associated with decreased depolarization-induced Ca 2+ influx in colonic smooth muscle that leads to attenuated myosin light chain phosphorylation and impaired colonic contractility.

KW - Colon

KW - Streptozotocin

KW - Voltage-gated calcium channel

UR - http://www.scopus.com/inward/record.url?scp=83755207104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83755207104&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00183.2011

DO - 10.1152/ajpgi.00183.2011

M3 - Article

C2 - 21979758

AN - SCOPUS:83755207104

VL - 302

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 1

ER -